Binding of Peptides Containing D‐Amino Acids to the Tsg101 Tumor Susceptibility Protein

Abstract

AbstractTsg101 is implicated in tumorigenesis and viral budding, and its inhibition through peptide binding is a potential therapeutic strategy. We utilized the crystal structure of the Tsg101‐PSAP complex from the protein databank in molecular dynamics studies on peptide‐Tsg101 interactions. To enhance peptide stability against enzymatic degradation, we designed peptides with L‐form terminal prolines and D‐form middle amino acids. These peptides also featured acetylated proline at the N‐terminus and amidated C‐terminus, increasing resistance to proteases. Virtual screening of 400 amino acid combinations identified promising peptide candidates and specific binding sites. Subsequent molecular dynamics simulations focused on the peptide PywP, which displayed strong binding stability at a novel Tsg101 site. Further simulations with variations of the D‐form amino acid ′w’ showed that 18 of 21 tested peptides, notably PyeP and PytP, remained firmly bound, highlighting their potential as Tsg101 inhibitors. These peptides also contain hydrophilic residues, potentially improving solubility and therapeutic delivery.